WO2014060942A3 - Compositions and methods of for the treatment of multiple sclerosis and neurodegenerative diseases - Google Patents

Compositions and methods of for the treatment of multiple sclerosis and neurodegenerative diseases Download PDF

Info

Publication number
WO2014060942A3
WO2014060942A3 PCT/IB2013/059357 IB2013059357W WO2014060942A3 WO 2014060942 A3 WO2014060942 A3 WO 2014060942A3 IB 2013059357 W IB2013059357 W IB 2013059357W WO 2014060942 A3 WO2014060942 A3 WO 2014060942A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
treatment
multiple sclerosis
neurodegenerative diseases
methods
Prior art date
Application number
PCT/IB2013/059357
Other languages
French (fr)
Other versions
WO2014060942A2 (en
Inventor
Mahesh Kandula
Original Assignee
Mahesh Kandula
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mahesh Kandula filed Critical Mahesh Kandula
Publication of WO2014060942A2 publication Critical patent/WO2014060942A2/en
Publication of WO2014060942A3 publication Critical patent/WO2014060942A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/08—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
    • C08G69/10—Alpha-amino-carboxylic acids

Abstract

The disclosures herein provide aminoacid derivatives containing therapeutic copolymer of formula I or its pharmaceutical acceptable salts, as well as polymorphs, enantiomers, stereoisomers, solvates, and hydrates thereof. These salts may be formulated as pharmaceutical compositions. The pharmaceutical compositions may be formulated for oral administration, intravenous, subdermal, transdermal administration, or injection. Such compositions aminoacid derivatives containing therapeutic copolymer may be used to treatment of multiple sclerosis and neurodegenerative diseases or its associated complications.
PCT/IB2013/059357 2012-10-20 2013-10-15 Compositions and methods of for the treatment of multiple sclerosis and neurodegenerative diseases WO2014060942A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN4383CH2012 2012-10-20
IN4383/CHE/2012 2012-10-20

Publications (2)

Publication Number Publication Date
WO2014060942A2 WO2014060942A2 (en) 2014-04-24
WO2014060942A3 true WO2014060942A3 (en) 2014-10-23

Family

ID=50488842

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2013/059357 WO2014060942A2 (en) 2012-10-20 2013-10-15 Compositions and methods of for the treatment of multiple sclerosis and neurodegenerative diseases

Country Status (1)

Country Link
WO (1) WO2014060942A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2019189133A1 (en) * 2018-03-27 2021-03-18 日油株式会社 Sphingomyelin-induced lipids and their production methods

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3849550A (en) * 1971-04-21 1974-11-19 Yeda Res & Dev Therapeutic copolymer
WO1995031990A1 (en) * 1994-05-24 1995-11-30 Yeda Research And Development Co., Ltd. Copolymer-1 improvements in compositions of copolymers
WO2006083608A1 (en) * 2005-02-02 2006-08-10 Teva Pharmaceutical Industries, Ltd. Process for producing polypeptide mixtures using hydrogenolysis
WO2009140765A1 (en) * 2008-05-21 2009-11-26 New World Laboratories Inc. Selective caspase inhibitors and uses thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3849550A (en) * 1971-04-21 1974-11-19 Yeda Res & Dev Therapeutic copolymer
WO1995031990A1 (en) * 1994-05-24 1995-11-30 Yeda Research And Development Co., Ltd. Copolymer-1 improvements in compositions of copolymers
WO2006083608A1 (en) * 2005-02-02 2006-08-10 Teva Pharmaceutical Industries, Ltd. Process for producing polypeptide mixtures using hydrogenolysis
WO2009140765A1 (en) * 2008-05-21 2009-11-26 New World Laboratories Inc. Selective caspase inhibitors and uses thereof

Also Published As

Publication number Publication date
WO2014060942A2 (en) 2014-04-24

Similar Documents

Publication Publication Date Title
PH12018500147A1 (en) Benzodiazepine derivatives as rsv inhibitors
TN2014000356A1 (en) Heterocyclyl compounds as mek inhibitors
NZ703064A (en) Inhibitors of hepatitis c virus
UA109698C2 (en) AZAINDASOL OR DIAZAINDASOL DERIVATIVES AS A MEDICINE
MX2016013529A (en) Amide derivatives and pharmaceutically acceptable salts thereof, preparation method therefor and medicinal application thereof.
MX2014004479A (en) Novel oxazine derivatives and their use in the treatment of disease.
EA032951B1 (en) Glutarimide derivative, use thereof, pharmaceutical composition based thereon, process for preparing same
WO2011085643A8 (en) Fused pyridine derivatives
WO2011097946A8 (en) Oxazolidinone compounds containing ring-fused bicyclic ring, preparation method and use thereof
MX2018002738A (en) Tricyclic fused pyridin-2-one derivatives and their use as brd4 inhibitors.
WO2014068463A3 (en) Compositions and methods for the treatment of inflammation and metabolic disorders
WO2013175359A3 (en) Compositions and methods for the treatment of multiple sclerosis
MY169215A (en) 3-o-heteroaryl-ingenol
WO2013106756A3 (en) Antimicrobial agents
MX2019006942A (en) Non-peptide oxytocin receptor agonists.
WO2014060942A3 (en) Compositions and methods of for the treatment of multiple sclerosis and neurodegenerative diseases
WO2014087323A3 (en) Compounds and compositions for the treatment of autoimmune and chronic metabolic diseases
WO2015028976A3 (en) Compounds and methods for the treatment of inflammatory diseases
WO2009111037A3 (en) Compositions and methods for treating nos-associated diseases
MX2014000870A (en) Pharmaceutical compositions comprising 4-bromo-n-(imidazolidin-2- ylidene)-1h-benzimidazol-5-amine for treating retinal diseases.
WO2012033983A3 (en) Candesartan pharmaceutical compositions
WO2014080309A3 (en) Compositions and methods for the treatment of inflammation and lipid disorders
MX2017008497A (en) Novel heterocyclic compounds and the use thereof in medicine and in cosmetics.
GB2544385A (en) Modulators of caspase-6
WO2014091467A3 (en) Compositions and methods for the treatment of autoimmune diseases and inflammation

Legal Events

Date Code Title Description
122 Ep: pct application non-entry in european phase

Ref document number: 13847594

Country of ref document: EP

Kind code of ref document: A2